Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacologic intervention for vascular calcification].

Hiroko Segawa1, Junya Furutani, Ken-ichi Miyamoto

  • 1Department of Molecular Nutrition Institution of Health Biosciences, The University of Tokushima Graduate School.

Clinical Calcium
|July 5, 2005
PubMed
Summary

Phosphate retention in dialysis patients contributes to vascular calcification. New phosphate binders are needed to overcome side effects and improve patient compliance in managing hyperphosphatemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aromatase in adipose tissue exerts an osteoprotective function in male mice via phosphate regulation.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study.

Drug metabolism and pharmacokinetics·2024
Same author

The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism.

Biomolecules·2024
Same author

Involvement of α-klotho in growth hormone (GH) signaling.

Journal of clinical biochemistry and nutrition·2024
Same author

Effects of EOS789, a novel pan-phosphate transporter inhibitor, on phosphate metabolism : Comparison with a conventional phosphate binder.

The journal of medical investigation : JMI·2023
Same author

Dietary polyphosphate has a greater effect on renal damage and FGF23 secretion than dietary monophosphate.

The journal of medical investigation : JMI·2022

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Phosphate retention is a significant complication in patients with chronic renal insufficiency and those undergoing dialysis.
  • This retention is a primary driver for the development of vascular calcification.
  • Current treatments for hyperphosphatemia, including various phosphate binders, present challenges such as hypocalcemia, toxicity, and constipation.

Purpose:

  • To highlight the critical role of phosphate retention in vascular calcification among dialysis patients.
  • To underscore the limitations and adverse effects associated with existing phosphate-binding therapies.
  • To emphasize the need for developing novel therapeutic agents with improved safety profiles and patient compliance.

Summary:

  • Phosphate retention is a major contributor to vascular calcification in patients with chronic kidney disease on dialysis.

Related Experiment Videos

  • Existing phosphate binders (e.g., calcium carbonate, sevelamer hydrochloride) often cause side effects like hypocalcemia and constipation, impacting patient adherence.
  • There is a clear clinical need for new, well-tolerated phosphate-lowering drugs to prevent vascular calcification and enhance treatment compliance.

    • Impact:

    • Improved management of hyperphosphatemia in renal insufficiency patients.
    • Potential reduction in the incidence of vascular calcification.
    • Enhanced patient quality of life through better treatment tolerability and compliance.